---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-071822"
form_type: "8-K"
ticker: "CLRB"
cik: "0001279704"
company_name: "Cellectar Biosciences, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:15:24.110815+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cellectar stockholders approve increase in share reserve by 7M shares, re-elect directors

## Summary
- Stockholders approved amendment to 2021 Stock Incentive Plan, increasing shares reserved by 7,000,000 (14.5M for, 1.06M against).
- Class I directors Asher Chanan-Khan and John Neis re-elected with 15.4M and 14.9M votes for, respectively.
- Ratification of Baker Tilly US, LLP as independent auditor for FY2024 approved (25.8M for, 183k against).
- Non-binding advisory vote on executive compensation approved (15.1M for, 436k against).
- No departures or other material changes reported.

## SEC filing metadata
- accession: 0001104659-24-071822
- form_type: 8-K
- ticker: CLRB
- cik: 0001279704
- company_name: Cellectar Biosciences, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1279704/000110465924071822/0001104659-24-071822-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1279704/000110465924071822/tm2417372d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-071822
- JSON: https://secwatch.observer/filing/0001104659-24-071822.json
- Plain text: https://secwatch.observer/filing/0001104659-24-071822.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.